STUDY ON EFFECTIVE COMBINATION AND ENHANCED EFFECTS OF ANTICANCERDRUGS
STUDY ON EFFECTIVE COMBINATION AND ENHANCED EFFECTS OF ANTICANCERDRUGS
批准号:
60440050
负责人:
SAKURAI Minoru
金额:
$11.01万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1985
资助国家:
日本
项目状态:
已结题
起止时间:
1985 至 1988
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. To clarify the therapeutic efficacy of anticancer combination chemotherapy, we analyzed intracellular active metabolites of drugs, and effects of these drugs on nucleic acid metabolism with high performance liquid chromatography. After treatment with methotrexate, reduction of intracelluar ATP, GTP, dTTP and dCTP levels were observed. Ara-C had significant effects on the growth of cells at the higher level of ara-CTP than of dCTP. So the dCTP/ara-CTP ratio is one of very important factors in ara-C cytotoxicity. The increased production of intracellular fluoro-UTP(FUTP) and ara-CTP by pretreatment with MTX were recognized. These enhanced effects were based on biochemical modulation in each grugs. VP16 and Ara-C combination chemotherapy showed similar modulation effects. 6TG was metabolized to 6-thioGMP, GDP, GTP. Major products of 6MP, however, was 6-thioIMP. Small quantity of 6-thioGMP was detected, but no 6-thioGDP, GTP were produced. The intracellular levels of ATP and GTP pools decreased after treatment with 6TG and 6MP. Intracellular dCTP, and dTTP pools have declined after exposure to 6TG, whereas not decline with 6MP. These results suggested that cytotoxic mechanism of 6TG include inhibition of both purine pathway and DNA synthesis and 6MP only inhibits purine pathway.2. Protein kinase C and phorbor diester receptor were related with pleiotropic drug resistance. Phorbor esters, also, were linked to the glucocorticoid-induced growth inhibition.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Masaru Ido: Cancer Research.
井户胜:癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
医学のあゆみ. 128-3. (1984)
医学史。128-3。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toshiki,Ookubo: European J.of Cancer and Clin.Onco.24. 1823-1828 (1988)
Toshiki,Ookubo:欧洲癌症与临床肿瘤杂志 24。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsutomu,Nobori: "Mechanism of Resistance to Anticancer Drugs and Trials of overcome Their Resistance" Jpn J.Clin. Heamatol.27,. 1460-1467 (1986)
Tsutomu,Nobori:“抗癌药物的耐药机制和克服其耐药性的试验”Jpn J.Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toshiki,Ookubo: "Sequence-dependent antitumor effect of VP-16 and 1- -D-arabinofuranosylcytosine in L1210 ascites tumor" European J.of Cancer and Clin. Onco.24. 1823-1828 (1988)
Toshiki,Ookubo:“VP-16 和 1-β-D-阿拉伯呋喃糖基胞嘧啶在 L1210 腹水肿瘤中的序列依赖性抗肿瘤作用”欧洲癌症与临床杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 35 条
Elucidation of biological functions of LEA proteins as a desiccation protectant and their industrial application
-
批准号:24370065
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2012
-
负责人:SAKURAI Minoru
-
依托单位:
Molecular mechanism of the desiccation tolerance induced by trehalose and LEA proteins in anhydrobiotic organisms
-
批准号:21370068
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2009
-
负责人:SAKURAI Minoru
-
依托单位:
Computional study of the spectral tuning and photoreaction of photoactive yellow protein
-
批准号:12680653
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:SAKURAI Minoru
-
依托单位:
Effect of anti-sense P-glycoprotein oligomer on P-glycoprotein-positive multidrug-resistant cancers
-
批准号:05454287
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1993
-
负责人:SAKURAI Minoru
-
依托单位:
海外基金